RenaissanceRe (RNR) Q2 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2024 earnings summary
2 Feb, 2026Executive summary
Net income available to common shareholders was $495.0M and operating income was $650.8M in Q2 2024, reflecting strong performance across underwriting, investment, and fee income.
Annualized operating return on average common equity was 28.2%, with average common equity up two-thirds year-over-year.
Gross premiums written rose 29.2% year-over-year to $3.43B, driven by both property and casualty/specialty segments and the Validus acquisition.
The Validus acquisition, completed in November 2023, continues to drive significant growth, diversification, and value accretion, with integration ahead of schedule.
Book value per common share increased 5.5% since year-end 2023, reaching $179.87 at June 30, 2024.
Financial highlights
Operating income was $651M; operating EPS was $12.41, up 40% year-over-year.
Net investment income increased 50% to $410.8M, reflecting higher average invested assets and yields.
Fee income grew 48% to $84.1M, with increases in both management and performance fees.
Underwriting income reached $479.3M, up from $351.0M in Q2 2023; combined ratio was 81.1%, adjusted combined ratio 78.6%.
Gross premiums written up 29% for the quarter and 36% year-to-date.
Outlook and guidance
Management expects continued strong performance and superior returns through 2024 and into 2025, supported by favorable business conditions and ongoing benefits from the Validus acquisition.
Management fees expected to remain around $55M in Q3; performance fees projected at $20M absent large losses.
Retained net investment income for Q3 expected to be flat; fixed maturity portfolio yield remains attractive.
Management anticipates increased income taxes in future periods due to Bermuda's new 15% corporate tax effective 2025.
The company remains focused on disciplined underwriting, capital management, and leveraging third-party capital for growth.
Latest events from RenaissanceRe
- Key votes include director elections, executive pay, incentive plan, and auditor appointment.RNR
Proxy Filing18 Mar 2026 - 2025 saw record returns, board refreshment, and enhanced ESG focus, with all proposals recommended for approval.RNR
Proxy Filing18 Mar 2026 - Net income hit $2.65B in 2025, with 30.8% book value growth despite major loss events.RNR
Q4 20254 Feb 2026 - Q3 net income soared to $1.17B, with strong premium growth and investment gains.RNR
Q3 202415 Jan 2026 - Record $2.2B operating income and 26% tangible book value growth despite catastrophe losses.RNR
Q4 20249 Jan 2026 - Catastrophe losses led to an operating loss, but investment gains and capital strength persisted.RNR
Q1 202520 Dec 2025 - 2024 saw record growth, strategic integration, and enhanced governance, with all proposals recommended for approval.RNR
Proxy Filing2 Dec 2025 - Key votes include director elections, executive pay, and auditor approval for 2025.RNR
Proxy Filing2 Dec 2025 - Q2 2025 net income rose 67% with a 75.1% combined ratio and strong book value growth.RNR
Q2 20255 Nov 2025